StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Goldenwell Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$110.37K. For fiscal 2025 it was -$22.63K. The highest annual figure on record is -$2.31K in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.63K–
FY2024Dec 31, 2024-$123.08K–
FY2023Dec 31, 2023-$113.15K–
FY2022Dec 31, 2022-$1.07M–
FY2021Dec 31, 2021-$205.14K–
FY2020Dec 31, 2020-$6.32K–
FY2019Dec 31, 2019-$2.31K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$47.27K-179.6%
Q1 FY2026Mar 31, 2026-$13.36K–
Q4 FY2025Dec 31, 2025-$18.85K–
Q3 FY2025Sep 30, 2025-$30.89K–
Q2 FY2025Jun 30, 2025$59.38K–
Q1 FY2025Mar 31, 2025-$32.28K–
Q4 FY2024Dec 31, 2024-$25.35K–
Q3 FY2024Sep 30, 2024-$20.97K–
Q2 FY2024Jun 30, 2024-$47.75K–
Q1 FY2024Mar 31, 2024-$29.01K–
Q4 FY2023Dec 31, 2023-$19.08K–
Q3 FY2023Sep 30, 2023-$35.21K-331.3%
Q2 FY2023Jun 30, 2023-$26.95K–
Q1 FY2023Mar 31, 2023-$31.92K–
Q4 FY2022Dec 31, 2022-$917.09K–
Q3 FY2022Sep 30, 2022$15.22K–
Q2 FY2022Jun 30, 2022-$25.04K–
Q1 FY2022Mar 31, 2022-$145.66K–
Q4 FY2021Dec 31, 2021-$19.37K–
Q3 FY2021Sep 30, 2021-$12.51K–
Q2 FY2021Jun 30, 2021-$150.20K–
Q1 FY2021Mar 31, 2021-$150.20K–
Q4 FY2020Dec 31, 2020-$2.98K–
Q3 FY2020Sep 30, 2020-$878–
Q2 FY2020Jun 30, 2020-$142–
Q1 FY2020Mar 31, 2020-$2.33K–
Q4 FY2019Dec 31, 2019-$2.31K–

More Goldenwell Biotech figures

See a number that looks wrong?